Researchers will evaluate if IFB-048 can protect nerve cells and/or oligodendrocytes, the brain cells mainly responsible for ...

Nektar and Biolojic Design worked to develop antibodies that target and activate the TNFR2 receptor, which is on the surface ...

A committee of the European Medicines Agency has recommended approval in the EU of under-the-skin Ocrevus injections to treat ...

Faced with a new cognitive symptom of multiple sclerosis, columnist Ben Hofmeister is relieved to find a possible explanation ...

Among immigrants to Canada, the risk of multiple sclerosis (MS) is higher for those who have spent a longer time in the ...

After her MS diagnosis, columnist Leigh Anne Nelson immediately thought about her children and wondered if the disease could ...

In MS, active lesions on MRI scans reflect inflammation, but there may be disease progression even when scans don’t show new ...

MS patients on Tysabri (natalizumab) prefer receiving it as a subcutaneous injection, according to data from an observational ...

A machine learning model can predict the risk of converting from clinically isolated syndrome (CIS) to multiple sclerosis (MS ...

May is MS Awareness Month in Canada, and MS Canada is asking residents to come together to call attention to the ...

A lower dose of vidofludimus calcium (IMU-838) was not as effective as higher doses at reducing lesions in people with RRMS, ...

Use of foralumab nasal spray was found to reduce fatigue levels in seven of 10 patients with nonactive SPMS in an expanded ...